Racial disparities in access to DBS: results of a real-world US claims data analysis

被引:1
|
作者
Frassica, Michael [1 ]
Kern, Drew S. [2 ,3 ]
Afshari, Mitra [4 ]
Connolly, Allison T. [1 ]
Wu, Chengyuan [5 ]
Rowland, Nathan [6 ]
Ramirez-Castaneda, Juan [7 ]
Ushe, Mwiza [8 ]
Salazar, Claudia [6 ,9 ]
Mason, Xenos [10 ,11 ]
机构
[1] Abbott Labs, Austin, TX USA
[2] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO USA
[3] Univ Colorado, Sch Med, Dept Neurosurg, Aurora, CO USA
[4] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL USA
[5] Thomas Jefferson Univ, Vickie & Jack Farber Inst Neurosci, Dept Neurol Surg, Philadelphia, PA USA
[6] Med Univ South Carolina, Dept Neurosurg, Charleston, SC USA
[7] Methodist Phys Neurosurg & Neurol Specialists, San Antonio, TX USA
[8] Washington Univ, Dept Neurol, St Louis, MO USA
[9] Med Univ South Carolina, Dept Neurosci, Charleston, SC USA
[10] Univ Southern Calif Los Angeles, Keck Sch Med, Dept Neurol, Los Angeles, CA 90007 USA
[11] Univ Southern Calif Los Angeles, Keck Sch Med, Dept Neurol Surg, Los Angeles, CA 90007 USA
来源
FRONTIERS IN NEUROLOGY | 2023年 / 14卷
关键词
deep brain stimulation; Parkinson's disease; essential tremor; medicare; race; ethnicity; telehealth; movement disorder; BRAIN-STIMULATION SURGERY; DIAGNOSIS;
D O I
10.3389/fneur.2023.1233684
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
IntroductionDeep brain stimulation (DBS) is an effective and standard-of-care therapy for Parkinson's Disease and other movement disorders when symptoms are inadequately controlled with conventional medications. It requires expert care for patient selection, surgical targeting, and therapy titration. Despite the known benefits, racial/ethnic disparities in access have been reported. Technological advancements with smartphone-enabled devices may influence racial disparities. Real-world evidence investigations can shed further light on barriers to access and demographic disparities for DBS patients. MethodsA retrospective cross-sectional study was performed using Medicare claims linked with manufacturer patient data tracking to analyze 3,869 patients who received DBS. Patients were divided into two categories: traditional omnidirectional DBS systems with dedicated proprietary controllers ("traditional"; n = 3,256) and directional DBS systems with smart controllers ("smartphone-enabled"; n = 613). Demographics including age, sex, and self-identified race/ethnicity were compared. Categorical demographics, including race/ethnicity and distance from implanting facility, were analyzed for the entire population. ResultsA significant disparity in DBS utilization was evident. White individuals comprised 91.4 and 89.9% of traditional and smartphone-enabled DBS groups, respectively. Non-White patients were significantly more likely to live closer to implanting facilities compared with White patients. ConclusionThere is great racial disparity in utilization of DBS therapy. Smartphone-enabled systems did not significantly impact racial disparities in receiving DBS. Minoritized patients were more likely to live closer to their implanting facility than White patients. Further research is warranted to identify barriers to access for minoritized patients to receive DBS. Technological advancements should consider the racial discrepancy of DBS utilization in future developments.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] RACIAL DISPARITIES IN HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANT IN US: A REAL-WORLD DATA STUDY
    Verma, V.
    Gaur, A.
    Sharma, S.
    Sachdev, A.
    Roy, A.
    Nayyar, A.
    Daral, S.
    Kukreja, I
    Brooks, L.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S362 - S362
  • [2] Racial and ethnic disparities in a real-world precision oncology data registry
    Cheung, Alexander T. M.
    Palapattu, Elina L. L.
    Pompa, Isabella R. R.
    Aldrighetti, Christopher M. M.
    Niemierko, Andrzej
    Willers, Henning
    Huang, Franklin
    Vapiwala, Neha
    Van Allen, Eliezer
    Kamran, Sophia C. C.
    [J]. NPJ PRECISION ONCOLOGY, 2023, 7 (01)
  • [3] Racial and ethnic disparities in a real-world precision oncology data registry
    Alexander T. M. Cheung
    Elina L. Palapattu
    Isabella R. Pompa
    Christopher M. Aldrighetti
    Andrzej Niemierko
    Henning Willers
    Franklin Huang
    Neha Vapiwala
    Eliezer Van Allen
    Sophia C. Kamran
    [J]. npj Precision Oncology, 7
  • [4] TO INVESTIGATE GENDER AND RACIAL DISPARITIES IN THE RESOURCE UTILIZATION OF PATIENTS WITH LUNG DISEASES IN THE US: A REAL-WORLD DATA STUDY
    Markan, R.
    Sharma, S.
    Verma, V.
    Gaur, A.
    Daral, S.
    Kukreja, I
    Nayyar, A.
    Roy, A.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S357 - S357
  • [5] Patients with Idiopathic Membranous Nephropathy: A Real-World Clinical and Economic Analysis of US Claims Data
    Nazareth, Tara A.
    Kariburyo, Furaha
    Kirkemo, Aaron
    Xie, Lin
    Pavlova-Wolf, Anna
    Bartels-Peculis, Laura
    Vaidya, Neel
    Sim, John J.
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (09): : 1011 - +
  • [6] Pathways of Escalation to Asthma Biologics in Real-world Clinical Practice: an Analysis of US Claims Data
    Brown, Randall
    Bender, Bruce
    Boe, Amanda
    Casciano, Julian
    Dotiwala, Zenobia
    Herrera, Ernesto Mayen
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB90 - AB90
  • [7] Racial disparities in the pharmacological treatment of insomnia: A time-to-event analysis using real-world data
    Holler, Emma
    Campbell, Noll L.
    Boustani, Malaz
    Dexter, Paul
    Ben Miled, Zina
    Owora, Arthur
    [J]. SLEEP HEALTH, 2023, 9 (02) : 128 - 135
  • [8] Epidemiology of AL amyloidosis: a real-world study using US claims data
    Quock, Tiffany P.
    Yan, Tingjian
    Chang, Eunice
    Guthrie, Spencer
    Broder, Michael S.
    [J]. BLOOD ADVANCES, 2018, 2 (10) : 1046 - 1053
  • [9] Real-world effectiveness of voxelotor for treating sickle cell disease in the US: a large claims data analysis
    Shah, Nirmish
    Lipato, Thokozeni
    Alvarez, Ofelia
    Delea, Thomas
    Lonshteyn, Alexander
    Weycker, Derek
    Nguyen, Andy
    Beaubrun, Anne
    Agodoa, Irene
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (02) : 167 - 173
  • [10] REAL-WORLD EFFECTIVENESS AND RACIAL/ETHNIC DISPARITIES IN IMMUNOTHERAPY FOR ADVANCED HEPATOCELLULAR CARCINOMA: ANALYSIS OF US NATIONAL CANCER DATABASE
    Ahn, Joseph C.
    Lauzon, Marie
    Luu, Michael
    Noureddin, Mazen
    Ayoub, Walid S.
    Kuo, Alexander
    Sundaram, Vinay
    Kosari, Kambiz
    Nissen, Nicholas N.
    Gong, Jun
    Hendifar, Andrew
    Roberts, Lewis R.
    Abou-Alfa, Ghassan K.
    Singal, Amit G.
    Yang, Ju Dong
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S1140 - S1140